Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record is now available, with details on the study design and treatments, eligibility criteria, locations, outcomes, and record history.
    Difference
    53%
    Check dated 2026-11-08T15:24:02.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:25:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the study page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T17:41:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:24:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:11:19.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating access to the content is blocked.
    Difference
    0.5%
    Check dated 2026-09-27T22:21:48.000Z thumbnail image

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.